Both in Pharmaceuticals
ADARx Pharmaceuticals vs Ultragenyx Pharmaceutical
Over the past year ADRX returned −22.9% and RARE returned +12.2%; their daily moves had a correlation of 0.19.
ADRX −22.9% RARE +12.2%Growth of $1, one year, split-adjusted
| Metric | ADRX | RARE |
|---|---|---|
| Price | $14.91 | $16.27 |
| Market cap | $1.59B | $1.66B |
| Today | +12.11% | −2.57% |
| 1 month | −16.4% | +9.2% |
| 6 months | — | −36.9% |
| Year to date | — | −29.3% |
| 1 year | — | −51.1% |
| Revenue growth (YoY) | — | +8.1% |
| Gross margin | — | 81.5% |
| Net margin | — | −68.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.3× |
| Net cash | — | $266.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 130.7% |
| Short % of float | 3.4% | 25.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).